News summary
Xiansheng Pharmaceutical (02096) passed a stock repurchase plan and invested 893 on May 14.galaxianarcadegame.50 million Hong Kong dollars, successfully acquiring 1.565 million shares.
Newsletter text
[Xiansheng Pharmaceutical (02096) spent nearly HK$9 million to implement share repurchase] On May 14, 2024, Xiansheng Pharmaceutical (02096) announced that it would spend HK$8.935 million to repurchase 1.565 million shares, demonstrating the company's commitment to its own valuegalaxianarcadegameconfidence.
This repurchase may have a positive impact on secondary market investors and raise the market's expectations for the company's future development.
Through this repurchase, Xiansheng Pharmaceutical demonstrated its strong financial strength and confidence in the company's continued growth in the future.